8 min listen
CardiaCast: New Hope in HF: The Evolving Evidence for SGLT2 Inhibitors
FromACC CardiaCast
ratings:
Length:
17 minutes
Released:
Jul 30, 2021
Format:
Podcast episode
Description
In this episode, Alanna Morris, MD, MSc, FACC; Javed Butler, MBBS, FACC; John McMurray, MD, FACC; and Muthiah Vaduganathan, MD, FACC, discuss the role of sodium-glucose transport protein 2 inhibitors in the new hope in heart failure (HF). Visit the Clinical Spotlight Series: Shining a Light on New HF Pharmacotherapies online course page for more information and resources. Educational Support provided by AstraZeneca, Cytokinetics, Merck Sharp & Dohme Corp., and Novartis Pharmaceuticals Corporation.
Released:
Jul 30, 2021
Format:
Podcast episode
Titles in the series (96)
ACC CardiaCast: Team-Based and Patient-Centered Care: This podcast discusses the importance of the patient to the care team, particularly regarding medication adherence, and considers the roles of the pharmacists, nurse practitioners, and physician assistants as well as the physician. by ACC CardiaCast